Cyclacel Pharmaceuticals, Inc. Announces Closing of Underwritten Offering of Common Stock and Warrants BERKELEY HEIGHTS, N.J. , July 7, 2011 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that it has closed its previously announced underwritten offering of an aggregate of 7,617,646 units at an offering price of $1.36 […]